American Research & Management Co. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.

Quarter-by-quarter ownership
American Research & Management Co. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$27,0000.0%6240.0%0.01%
+16.7%
Q1 2022$27,000
-3.6%
6240.0%0.01%0.0%
Q4 2021$28,000
+16.7%
6240.0%0.01%0.0%
Q3 2021$24,000
-7.7%
624
-3.9%
0.01%0.0%
Q2 2021$26,000
+13.0%
6490.0%0.01%0.0%
Q1 2021$23,000
+155.6%
649
+159.6%
0.01%
+200.0%
Q4 2020$9,0000.0%2500.0%0.00%
-33.3%
Q3 2020$9,000
-10.0%
2500.0%0.00%0.0%
Q2 2020$10,000
+11.1%
2500.0%0.00%0.0%
Q1 2020$9,000
-43.8%
250
-28.6%
0.00%
-40.0%
Q4 2019$16,000
+6.7%
3500.0%0.01%0.0%
Q3 2019$15,000
+7.1%
3500.0%0.01%
+25.0%
Q2 2019$14,000
-75.0%
350
-74.1%
0.00%
-75.0%
Q1 2019$56,000
+330.8%
1,350
+285.7%
0.02%
+300.0%
Q4 2018$13,000
-40.9%
350
-36.4%
0.00%
-42.9%
Q3 2018$22,0000.0%5500.0%0.01%
-12.5%
Q2 2018$22,000
+4.8%
5500.0%0.01%
+14.3%
Q1 2018$21,000
+5.0%
5500.0%0.01%
+16.7%
Q4 2017$20,000
-9.1%
5500.0%0.01%
-14.3%
Q3 2017$22,000
-8.3%
5500.0%0.01%
-12.5%
Q2 2017$24,000
+4.3%
5500.0%0.01%0.0%
Q1 2017$23,0000.0%550
-8.3%
0.01%0.0%
Q4 2016$23,000
-11.5%
6000.0%0.01%
-11.1%
Q3 2016$26,0000.0%6000.0%0.01%
-10.0%
Q2 2016$26,000
+8.3%
6000.0%0.01%0.0%
Q1 2016$24,0000.0%6000.0%0.01%0.0%
Q4 2015$24,000
-14.3%
600
-17.2%
0.01%
-16.7%
Q3 2015$28,000
-6.7%
7250.0%0.01%0.0%
Q2 2015$30,000
-9.1%
7250.0%0.01%
-7.7%
Q1 2015$33,000
+6.5%
7250.0%0.01%
+18.2%
Q4 2014$31,000
-6.1%
7250.0%0.01%
-8.3%
Q3 2014$33,000
-25.0%
725
-12.1%
0.01%
-20.0%
Q2 2014$44,000
+33.3%
825
+32.0%
0.02%
+25.0%
Q1 2014$33,0000.0%6250.0%0.01%0.0%
Q4 2013$33,000
+6.5%
6250.0%0.01%0.0%
Q3 2013$31,0000.0%6250.0%0.01%0.0%
Q2 2013$31,0006250.01%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2022
NameSharesValueWeighting ↓
JTC Employer Solutions Trustee Ltd 6,324,319$241,621,00032.36%
Black Creek Investment Management Inc. 10,329,349$394,684,00011.46%
Healthcare Value Capital, LLC 100,000$3,821,0007.54%
KAHN BROTHERS GROUP INC 1,353,358$51,711,809,0007.28%
EQUITY INVESTMENT CORP 2,924,326$111,738,0004.28%
Eversept Partners, LP 1,503,700$57,456,3773.99%
NKCFO LLC 269,500$10,298,0003.45%
Robinson Value Management, Ltd. 96,990$3,706,0003.31%
Keystone Financial Planning, Inc. 237,691$9,082,0003.30%
CLIFFORD CAPITAL PARTNERS LLC 93,485$3,572,0003.27%
View complete list of GLAXOSMITHKLINE PLC shareholders